Andrew Bellinger - 14 Dec 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
CSO & CMO
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
Issuer symbol
VERV
Transactions as of
14 Dec 2022
Net transactions value
+$103,320
Form type
4
Filing time
16 Dec 2022, 16:00:34 UTC
Previous filing
02 Dec 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Options Exercise $103,320 +36,000 +543% $2.87* 42,629 14 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Options Exercise $0 -36,000 -17% $0.000000 179,994 14 Dec 2022 Common Stock 36,000 $2.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The remaining shares underlying this option, which was granted on September 16, 2020, vest in equal monthly installments until September 16, 2024.